CLBS Market Cap History



Below is a table of the CLBS market cap history going back to 8/5/2016:

Date CLBS Market Cap
8/5/201636.96M
11/1/201631.62M
3/16/201742.37M
5/10/201743.81M
8/8/201734.49M
11/6/201728.13M
3/22/201858.18M
5/6/201840.58M
8/7/201847.36M
11/7/201848.13M
3/8/201936.82M
5/8/201931.15M
8/8/201927.88M
8/22/201915.68M
11/5/201922.26M
3/5/202025.21M
5/6/202024.27M
8/13/202041.54M
11/3/202030.84M
2/25/2021113.66M
5/6/202189.84M
8/5/202176.78M
11/4/202169.94M
3/22/202244.79M
5/5/202231.47M
8/4/202231.50M

Also see: CLBS Shares Outstanding History
and CLBS YTD Return
CLBS Historical Market Cap:
-2.63% CAGR
CLBS Historical Market Cap: +-2.63% CAGR

Mouse over chart for data details
8/5/2016 ...8/4/2022
Caladrius Biosciences is a clinical-stage biopharmaceutical company focused on the development of treatments and reversal of severe diseases. Co.'s product candidates include: XOWNA®, which is a Phase 2a study and an ongoing follow-on Phase 2b study in the U.S. for the treatment of coronary microvascular dysfunction; HONEDRA®, which is eligible for early conditional approval in Japan for the treatment of critical limb ischemia based on the results of a clinical trial; and CLBS201, which is designed to assess the safety and efficacy of CD34+ cell therapy as a treatment for patients with chronic kidney disease related to type 2 diabetes. We show 26 historical shares outstanding datapoints in our CLBS shares outstanding history coverage, used to compute CLBS market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing CLBS market cap history over the course of time is important for investors interested in comparing CLBS's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of CLBS versus a peer is one thing; comparing CLBS market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like CLBS can fluctuate over the course of history. With this page we aim to empower investors researching CLBS by allowing them to research the CLBS market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree CLBS Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Caladrius Biosciences (CLBS) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

CLDX Market Cap History
CLNN Market Cap History
CLOV Market Cap History
CLPT Market Cap History
CLRB Market Cap History
CLSD Market Cap History
CLSN Market Cap History
CLVS Market Cap History
CLXT Market Cap History
CMAX Market Cap History
More Healthcare companies »

 

CLBS Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.